What Is Carbon Dioxide Therapy

Carbon dioxide therapy is a medical and aesthetic treatment that introduces carbon dioxide gas into body tissues, either by subcutaneous injection (carboxytherapy), transdermal absorption through CO2-enriched baths or gels, or insufflation. The gas triggers local vasodilation and exploits the Bohr effect to increase oxygen release from hemoglobin, thereby improving tissue perfusion and oxygenation. The practice has roots in European balneotherapy, where natural CO2 mineral springs have been used therapeutically for centuries.

Tissue oxygenation sits at the center of healing, metabolic health, and cellular function. As the body ages, microvascular circulation declines, contributing to slower wound healing, reduced skin quality, and impaired organ function. Any intervention that reliably improves local blood flow and oxygen delivery has relevance to both recovery and long-term tissue maintenance.

Carbon dioxide therapy is notable because it leverages a molecule the body already produces as a metabolic byproduct. Rather than introducing a foreign substance, it amplifies a physiological mechanism (the Bohr effect) that governs how efficiently cells receive oxygen. This positions CO2 therapy within a broader interest in optimizing oxygen utilization, a factor that connects to cardiovascular health, wound repair, and the metabolic efficiency that tends to decline with age.

The core mechanism of carbon dioxide therapy rests on two well-established physiological responses. First, when CO2 concentrations rise in local tissue, arterioles dilate. This vasodilation occurs because CO2 acts on smooth muscle cells in blood vessel walls, causing them to relax. The result is increased blood flow to the treated area, bringing more nutrients and immune cells while carrying away metabolic waste.

Second, elevated CO2 shifts the oxygen-hemoglobin dissociation curve to the right, a phenomenon described by the Bohr effect. Hemoglobin holds oxygen more loosely in the presence of CO2 and lower pH, meaning oxygen is released more readily into surrounding tissue. This dual action (more blood arriving and more oxygen being unloaded from that blood) creates a potent local increase in tissue oxygenation.

In subcutaneous carboxytherapy, medical-grade CO2 is injected through a fine needle at controlled flow rates. The gas diffuses through local tissue, triggering vasodilation and the Bohr effect before being absorbed into the bloodstream and eventually exhaled through the lungs. In transcutaneous approaches, CO2 is delivered through warm water baths saturated with the gas, or via topical gels that release CO2 against the skin. Transcutaneous absorption is slower but produces similar hemodynamic effects in the treated area. Some protocols use dry CO2 gas bags that envelop a limb, allowing percutaneous absorption without immersion in water.

A subcutaneous carboxytherapy session begins with the practitioner connecting a medical-grade CO2 tank to a flow regulator and a sterile needle or cannula. The gas is injected just beneath the skin at low, controlled flow rates. You may feel pressure, mild stinging, or a crackling sensation as the gas spreads through tissue. The treated area may appear temporarily swollen or reddened, typically resolving within 30 minutes to a few hours. Sessions usually last 15 to 30 minutes depending on the size of the area being treated.

For transcutaneous CO2 therapy, the experience is gentler. In a CO2 bath, you sit in warm water infused with dissolved carbon dioxide, similar to soaking in a natural mineral spring. The skin may tingle as CO2 is absorbed. Dry CO2 applications involve wrapping the target area in a gas-filled bag or applying a CO2-releasing gel. These sessions typically last 20 to 45 minutes, and most people find them relaxing rather than uncomfortable.

For vascular and wound-healing applications, an initial series of 10 to 20 sessions is common, typically administered two to three times per week. Maintenance sessions may follow at wider intervals, such as monthly or quarterly, depending on clinical response. For aesthetic carboxytherapy, practitioners often recommend six to twelve sessions spaced one to two weeks apart, with periodic maintenance treatments.

Transcutaneous CO2 baths in the balneotherapy tradition are frequently prescribed as daily sessions over a two to four week course, reflecting the spa rehabilitation model common in central Europe. The cumulative nature of the circulatory benefits means that isolated single sessions are unlikely to produce lasting effects; consistent series-based treatment is the standard approach across all delivery methods.

Subcutaneous carboxytherapy sessions in the United States and comparable markets typically range from $75 to $250 per session, with cost varying by geographic area, practitioner credentials, and the size of the treatment zone. A full initial series of eight to twelve sessions can therefore cost $600 to $3,000. Transcutaneous CO2 bath therapy, where available outside of European spa facilities, tends to be priced similarly per session. In European countries with established balneotherapy infrastructure, CO2 baths may be significantly less expensive and are sometimes partially reimbursed by health insurance when prescribed for documented vascular conditions. Package pricing and bundled series are common, often reducing the per-session cost.

The evidence base for carbon dioxide therapy is substantial in some areas and thin in others. European clinical research, particularly from Germany, Italy, and the Czech Republic, has studied CO2 baths (balneotherapy) for decades in the context of peripheral arterial disease, with multiple controlled trials showing improvements in walking distance, skin perfusion, and wound healing in patients with circulatory disorders. These findings are consistent enough that CO2 balneotherapy is covered by some European health insurance systems for vascular rehabilitation.

For subcutaneous carboxytherapy in aesthetic applications (cellulite reduction, skin laxity, localized fat), the evidence is weaker. Several small trials and case series suggest improvements in skin elasticity and cellulite appearance, but most studies lack blinding, use small sample sizes, and rely on subjective outcome measures. Rigorous, large-scale randomized trials for these indications remain scarce. Research into CO2 therapy for chronic wounds, particularly diabetic ulcers, shows more consistent results, with transcutaneous CO2 application demonstrating improved transcutaneous oxygen pressure and wound closure rates in several controlled studies. The overall picture is one of a physiologically plausible therapy with solid mechanistic grounding, variable clinical evidence depending on the application, and a need for larger confirmatory trials in most use cases.

Carbon dioxide therapy is generally well tolerated. Subcutaneous injection may cause transient bruising, local discomfort, and a sensation of crepitus (crackling under the skin) that resolves as the gas is absorbed. Serious complications are rare but theoretically include air embolism if injection technique is poor, and tissue emphysema if flow rates are excessive. Transcutaneous methods carry minimal risk beyond mild skin irritation. People with severe uncompensated heart failure, respiratory insufficiency, or acute thrombotic events should be evaluated individually before treatment, as hemodynamic shifts from vasodilation could be clinically relevant in these populations.